This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (101)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Endophthalmitis  • Macular Disorders  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic

Daniel B. Roth, MD; Janet Chieh, BA; Marc J. Spirn, MD; Stuart N. Green, MD; David L. Yarian, MD; Nauman A. Chaudhry, MD

Arch Ophthalmol. 2003;121:1279-1282.

Background  Intravitreal injection of triamcinolone has been advocated to treat exudative macular diseases such as macular edema and choroidal neovascularization.

Objective  To describe 7 patients who developed a clinical picture simulating endophthalmitis after intravitreal triamcinolone injection.

Methods  Intravitreal triamcinolone injections were performed to treat refractory cystoid macular edema or diffuse macular edema associated with diabetic retinopathy, macular pucker, branch retinal vein occlusion, or pseudophakia. One patient received an injection in an attempt to treat exudation associated with occult choroidal neovascularization.

Results  Preinjection visual acuity ranged from 20/50 to 20/400. An extensive inflammatory response developed 1 to 2 days after injection in all 7 eyes. Five eyes had previously undergone vitrectomy. Four eyes had a layered hypopyon. All 7 eyes had an anterior chamber cellular reaction and vitritis. Visual acuity ranged from 20/400 to hand movements. The first 6 patients were treated for presumed endophthalmitis with vitreous cultures and intravitreal injections of antibiotics. All 6 cultures were negative for any organisms, and the eyes resolved their inflammatory response, with recovery to preinjection visual acuity or better. The seventh patient was treated with topical prednisolone without antibiotic therapy, and the inflammation resolved, with resolution of the macular edema seen before the intravitreal triamcinolone injection.

Conclusion  It may be appropriate to closely observe noninfectious, toxic endophthalmitis in patients treated with intravitreal triamcinolone before assuming it to be infectious, especially in the absence of eye pain.

From the Retina Vitreous Center, Department of Ophthalmology, University of Medicine and Dentistry of New Jersey (Drs Roth, Spirn, Green, and Yarian and Ms Chieh), New Brunswick; and New England Retina Associates (Dr Chaudhry), New London, Conn. The authors have no relevant financial interest in this article.

RELATED LETTER

Sterile Endophthalmitis After Benzyl Alcohol–Filtered Triamcinolone Acetonide Injection
José Lorenzo Carrero, Miguel González Barcia, and Ines Pérez Flores
Arch Ophthalmol. 2008;126(1):142-143.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide
Jonisch et al.
Br. J. Ophthalmol. 2008;92:1051-1054.
ABSTRACT | FULL TEXT  

Sterile Endophthalmitis After Benzyl Alcohol Filtered Triamcinolone Acetonide Injection
Lorenzo Carrero et al.
Arch Ophthalmol 2008;126:142-143.
FULL TEXT  

Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study)
Paccola et al.
Br. J. Ophthalmol. 2008;92:76-80.
ABSTRACT | FULL TEXT  

Effects of triamcinolone acetonide injections with and without preservative
Jonas
Br. J. Ophthalmol. 2007;91:1099-1101.
FULL TEXT  

Cytotoxicity of Triamcinolone Acetonide on Human Retinal Pigment Epithelial Cells
Chang et al.
IOVS 2007;48:2792-2798.
ABSTRACT | FULL TEXT  

Treatment of Cystoid Macular Edema in Retinitis Pigmentosa With Intravitreal Triamcinolone
Scorolli et al.
Arch Ophthalmol 2007;125:759-764.
ABSTRACT | FULL TEXT  

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study
Montero and Ruiz-Moreno
Br. J. Ophthalmol. 2007;91:131-133.
FULL TEXT  

Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.
Deng et al.
IOVS 2006;47:1516-1521.
ABSTRACT | FULL TEXT  

Should corticosteroids be considered as part of the standard care with photodynamic therapy?
Zarbin
Arch Ophthalmol 2006;124:563-571.
FULL TEXT  

Toxicity of Triamcinolone Acetonide on Retinal Neurosensory and Pigment Epithelial Cells
Narayanan et al.
IOVS 2006;47:722-728.
ABSTRACT | FULL TEXT  

Electroretinographic Effects of an Intravitreal Injection of Triamcinolone in Rabbit Retina
Dierks et al.
Arch Ophthalmol 2005;123:1563-1569.
ABSTRACT | FULL TEXT  

Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema: A Randomized Clinical Trial
Bonini-Filho et al.
IOVS 2005;46:3845-3849.
ABSTRACT | FULL TEXT  

Acute Endophthalmitis Incidence: Intravitreal Triamcinolone
Westfall et al.
Arch Ophthalmol 2005;123:1075-1077.
ABSTRACT | FULL TEXT  

Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema
Spandau et al.
Br. J. Ophthalmol. 2005;89:999-1003.
ABSTRACT | FULL TEXT  

Anterior Chamber Transit of Triamcinolone After Intravitreal Injection
Ruiz-Moreno et al.
Arch Ophthalmol 2005;123:129-130.
FULL TEXT  

Diffuse Intraocular Dispersion of Triamcinolone Particles as a Cause of Sterile Endophthalmitis
Chen et al.
Arch Ophthalmol 2004;122:1733-1733.
FULL TEXT  

Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study
Ciardella et al.
Br. J. Ophthalmol. 2004;88:1131-1136.
ABSTRACT | FULL TEXT  

Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide
Jonas and Bleyl
Br. J. Ophthalmol. 2004;88:839-840.
FULL TEXT  

Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema
Chen et al.
Br. J. Ophthalmol. 2004;88:843-844.
FULL TEXT